Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/25 16:21 | 4/1/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | 3 | S | -408 | 13.61 | 0 | -30 | 142 | D | ||||||||||||||||
4/3/25 16:21 | 4/2/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Topper David Joseph | CA | O | CFO | 1 | S | -152 | 15.80 | 0 | -10 | 183 | D | |||||||||||||||
3/26/25 16:41 | 3/24/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | 4 | S.dm | -658 | 13.37 | 0 | -49 | 1,161 | D | |||||||||||||||
3/17/25 16:51 | 3/13/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 4 | S.dm | -1,124 | 11.89 | 0 | -95 | 166 | D | |||||||||||||||
3/17/25 16:51 | 3/13/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 4 | M.dm | 1,124 | 11.89 | 0 | 95 | 132 | 166 | D | ||||||||||||||
3/4/25 19:43 | 3/3/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | 2 | S.d | -148 | 12.79 | 0 | -12 | 209 | D | |||||||||||||||
2/4/25 20:00 | 2/3/25 | ARQT | Health | Drug | Pharmaceutical Preparations | Edwards Larry Todd | CA | O | See Rema | 1 | S | -28 | 12.70 | 0 | -2 | 136 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |